Sort
51,593 grants matching “hepatitis”
Case Proteomics Center for HIV/AIDS and Drug Abuse
$994,371Mark R Chance · Case Western Reserve University · P20 · FY2010 · DA
Water Contaminants and Cardiovascular Risk: the Jackson Heart Study
$994,023April P Carson · University Of Mississippi Med Ctr · R01 · FY2025 · HL
Characterizing Alcohol's Effects on Repair of Liver Injury
$993,948Anna Mae Elizabeth Diehl · Duke University · RC2 · FY2009 · AA
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes
$993,807Dung "zung" Thai · Remd Biotherapeutics, Inc. · R44 · FY2020 · DK
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes
$993,807Dung "zung" Thai · Remd Biotherapeutics, Inc. · R44 · FY2021 · DK
Advancing a novel potent Zika virus specific nucleoside analog to the clinic
$993,605Klaus Klumpp · Riboscience, Llc · R44 · FY2017 · AI
Midwest Developmental Center for AIDS Research (D-CFAR)
$993,578Elvin H. Geng · Washington University · P30 · FY2025 · AI
Assessment of Multiple Dose Administration of Glucagon Receptor Blocker REMD477 in Type 1 Diabetes
$993,326Dung "zung" Thai · Remd Biotherapeutics, Inc. · R44 · FY2019 · DK
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
$993,323Cindy Ann Burklow · Naprogenix, Inc · U44 · FY2023 · AA
Targeting SWELL1 Signaling to Treat Obesity-Induced Type 2 Diabetes
$993,178Daniel J Lerner · Senseion Therapeutics, Inc. · R44 · FY2021 · DK
Acute Hepatitis C Infection in Young Injectors
$992,772Kimberly Page · University Of California, San Francisco · R01 · FY2011 · DA
The Development of a Web-based Data Retrieval System for HIV Therapy Guidance
$992,666Colombe Chappey · Monogram Biosciences, Inc. · R44 · FY2007 · AI
Subcutaneous Drug Development for Portal Hypertension Ascites
$992,469Gerardo M. Castillo · Pharmain Corporation · R44 · FY2021 · DK
Host Immune Responses to Antigens of Malaria Parasites
$992,457Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study
$992,255Linda A Teplin · Northwestern University At Chicago · R01 · FY2010 · DA
Agonists of the RIG-I Innate Immune Pathway
$992,047Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2011 · AI
RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES
$992,040University Of Florida · P01 · FY2002 · DK
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
$992,040Jay L Rothstein · Immunext, Inc. · R44 · FY2018 · AI
Role of IgG Fc Glycan Composition in Vaccination
$991,876Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2018 · AI
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
$991,804Jay L Rothstein · Immunext, Inc. · R44 · FY2017 · AI
Role of the Omentum in the Treatment of Morbid Obesity
$991,557Naji N Abumrad · Vanderbilt University · R01 · FY2009 · DK
Washington Entrepreneurial Research Evaluation and Commercialization Hub
$991,450Rodney J.y. Ho · University Of Washington · U01 · FY2019 · HL
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
$991,379Jonathan A Winger · Omniox, Inc. · R44 · FY2025 · HD
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations
$991,311Marianna K Baum · Florida International University · U01 · FY2022 · DA
Establishment/Maintenance of Biomedical Research Colony
$991,259Thomas J. Rowell · University Of Louisiana At Lafayette · U42 · FY2007 · RR